生物活性 | |||
---|---|---|---|
描述 | D-pinitol, a compound isolated from Pinaceae and Leguminosae plants, possess insulin-like properties. D-pinitol was administrated to the diabetic rats as two doses [30, 60 mg/(kg·body weight·day)]. The level of fasting blood glucose (FBG) was decreased 12.63% in the high-dosage group, and the ability of oral glucose tolerance was improved in D-pinitol-treated groups[3]. D-pinitol enhanced glucose-induced insulin secretion, which may account to enhances hepatic lipogenesis and TG (triglycerides) deposition in MPIN mice[4]. D-pinitol increased the concentration of nitrite, which was inhibited by L-NAME and calmidazolium (10 μM). D-pinitol increased the phosphorylation level of eNOS activation site at Ser1177 and reduced the phosphorylation level of its inactivation site at Thr495. In normotensive mice, the intraperitoneal administration of D-pinitol (10 mg/kg) induced a significant reduction of the SBP after 30 min[5]. D-pinitol treatment induces the apoptosis in human leukemic cells by generating intracellular ROS and modulating apoptotic protein expression[6]. D-pinitol ameliorated the skin abrasion and abridged epithelial thickness, inflammation numbers, and collagen-occupied regions in IMQ-induced psoriasis-like mice[7]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00470418 | Alzheimer Disease ... 展开 >> Dementia 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> VA Medical Center, Bronx Bronx, New York, United States, 10468 收起 << |
NCT00470418 | - | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
5.15mL 1.03mL 0.51mL |
25.75mL 5.15mL 2.57mL |
51.50mL 10.30mL 5.15mL |
参考文献 |
---|